MedTech News
A smart bandage clears a new hurdle by monitoring chronic wounds in human patients
Caltech professor of medical engineering Wei Gao and his colleagues are envisioning a smart bandage of the future—a “lab on skin” that could not only help patients and caregivers monitor the status of chronic wounds but also deliver treatment and speed up the healing process for those cuts, incisions, scrapes, and burns that are slow to heal on their own.
3D bioprinting uses collagen to bring vascularized tissue one step closer
This advancement expands the capabilities of how researchers can study disease and build tissues for therapy, such as type 1 diabetes.
Wearable device tracks individual cells in the bloodstream in real time
The technology, which achieves single-cell resolution, could help in continuous, noninvasive patient assessment to guide medical treatments.
Epiminder wins FDA de novo nod for implantable continuous EEG monitor
Epiminder announced today that it received FDA de novo authorization for its implantable continuous electroencephalogram monitoring (iCEM) system.
NeuroOne completes FDA submission for nerve ablation tech to treat facial pain
NeuroOne (Nasdaq:NMTC) announced today that it filed an FDA 510(k) submission for its trigeminal nerve ablation technology.
New Forensic Tool Detects 7 Drugs in Under 5 Minutes
SAN DIEGO, April 23, 2025 /PRNewswire/ — Biolabs International LLC proudly introduces PowderTracer™, a groundbreaking, rapid surface test, and its companion app, designed to swiftly detect seven dangerous drugs. This innovative tool is poised to revolutionize forensic drug detection in the field, providing accurate results in under five minutes. PowderTracer™ addresses the urgent need for rapid, reliable drug identification, particularly in the face of the escalating opioid crisis and the increasingly sophisticated methods used by drug traffickers.
Drug uptake discovery could allow IV medications to be taken orally
A team of scientists has uncovered the mechanism of cellular uptake for large and polar drugs and devised a novel strategy to optimize the capacity of drug-delivery into these cells. The team was led by Hong-yu Li, Ph.D., professor of medicinal chemistry and chemical biology with the Department of Pharmacology and the Barshop Institute at the University of Texas Health Science Center at San Antonio (UT Health San Antonio), together with teams from Duke University (Duke) and the University of Arkansas for Medical Sciences (UAMS)
Orchestra BioMed wins FDA breakthrough nod for hypertension treatment
Orchestra BioMed (Nasdaq:OBIO) announced today that it received FDA breakthrough device designation for its atrioventricular interval modulation (AVIM) therapy.